Rifampin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Rifampin Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 02/17/2021. Reported reason: Delay in shipping of the drug
Shortage Details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-351-20
- Dosage Form
- Injection
- Presentation
- Rifampin, Injection, 600 mg (NDC 63323-351-20)
- Initial Posting
- 02/17/2021
- Revised Date
Reason
Delay in shipping of the drug